Pub. Date : 2012 May-Jun
PMID : 22687377
7 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | These changes were accompanied by a significant reduction of p21(WAF1/Cip1) levels, where celecoxib sensitized the cells to sorafenib-mediated p21(WAF1/Cip1) suppression. | Sorafenib | cyclin dependent kinase inhibitor 1A | Homo sapiens |
| 2 | These changes were accompanied by a significant reduction of p21(WAF1/Cip1) levels, where celecoxib sensitized the cells to sorafenib-mediated p21(WAF1/Cip1) suppression. | Sorafenib | cyclin dependent kinase inhibitor 1A | Homo sapiens |
| 3 | These changes were accompanied by a significant reduction of p21(WAF1/Cip1) levels, where celecoxib sensitized the cells to sorafenib-mediated p21(WAF1/Cip1) suppression. | Sorafenib | cyclin dependent kinase inhibitor 1A | Homo sapiens |
| 4 | These changes were accompanied by a significant reduction of p21(WAF1/Cip1) levels, where celecoxib sensitized the cells to sorafenib-mediated p21(WAF1/Cip1) suppression. | Sorafenib | cyclin dependent kinase inhibitor 1A | Homo sapiens |
| 5 | CONCLUSION: These results suggest that combined treatment with sorafenib and celecoxib synergistically induce growth inhibition and apoptosis in pancreatic adenocarcinoma cells through a process involving p21(WAF1/Cip1) suppression. | Sorafenib | cyclin dependent kinase inhibitor 1A | Homo sapiens |
| 6 | CONCLUSION: These results suggest that combined treatment with sorafenib and celecoxib synergistically induce growth inhibition and apoptosis in pancreatic adenocarcinoma cells through a process involving p21(WAF1/Cip1) suppression. | Sorafenib | cyclin dependent kinase inhibitor 1A | Homo sapiens |
| 7 | CONCLUSION: These results suggest that combined treatment with sorafenib and celecoxib synergistically induce growth inhibition and apoptosis in pancreatic adenocarcinoma cells through a process involving p21(WAF1/Cip1) suppression. | Sorafenib | cyclin dependent kinase inhibitor 1A | Homo sapiens |